Study finds no short-term heart risks from ADHD drugs in adults

02/26/2013 | DailyRx.com

Researchers looked at the records of nearly 300,000 adult patients with attention-deficit/hyperactivity disorder and found that those who took amphetamines or atomoxetine were not more likely to develop stroke, heart attack or other serious heart problems during the first few months of treatment than those who didn't take the drugs. The study appeared in the journal PLoS One.

View Full Article in:

DailyRx.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC